Liver Transplantation for Alcoholic Liver Disease: A Devilish Dilemma

by Stephen E Congly, Samuel S Lee
Published 2013-01-01

Prediction of Bleeding Etiology: The Clinician is Vindicated!

by Stephen E Congly, Alexander I Aspinall
Published 2012-01-01

Screening for Hepatocellular Carcinoma in Patients with Hepatitis B

by Yashasavi Sachar, Mayur Brahmania, Renumathy Dhanasekaran, Stephen E. Congly
Published 2021-07-01

Modelling the cost effectiveness of non-alcoholic fatty liver disease risk stratification strategies in the community setting.

by Stephen E Congly, Abdel Aziz Shaheen, Mark G Swain
Published 2021-01-01

Treatment of moderate to severe respiratory COVID-19: a cost-utility analysis

by Stephen E. Congly, Rhea A. Varughese, Crystal E. Brown, Fiona M. Clement, Lynora Saxinger
Published 2021-09-01

Long-Term Follow-up and Quantitative Hepatitis B Surface Antigen Monitoring in North American Chronic HBV Carriers

by Conar R. O’Neil, Stephen E. Congly, M. Sarah Rose, Samuel S. Lee, Meredith A. Borman, Carmen L. Charlton, Carla Osiowy, Mark G. Swain, Kelly W. Burak, Carla S. Coffin
Published 2018-03-01

The cirrhosis care Alberta (CCAB) protocol: implementing an evidence-based best practice order set for the management of liver cirrhosis - a hybrid type I effectiveness-implementat...

by Michelle Carbonneau, Ejemai Amaize Eboreime, Ashley Hyde, Denise Campbell-Scherer, Peter Faris, Leah Gramlich, Ross T. Tsuyuki, Stephen E. Congly, Abdel Aziz Shaheen, Matthew Sadler, Marilyn Zeman, Jude Spiers, Juan G. Abraldes, Benjamin Sugars, Winnie Sia, Lee Green, Dalia Abdellatif, Jeffrey P. Schaefer, Vijeyakumar Selvarajah, Kaleb Marr, David Ryan, Yolande Westra, Neeja Bakshi, Jayant C. Varghese, Puneeta Tandon
Published 2020-06-01